Filing Details
- Accession Number:
- 0001437749-24-026536
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-08-13 21:09:49
- Reporting Period:
- 2024-08-12
- Accepted Time:
- 2024-08-13 21:09:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1401667 | Puma Biotechnology Inc. | PBYI | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1236514 | Patrick Michael Miller | C/O Puma Biotechnology, Inc. 10880 Wilshire Blvd., Suite 2150 Los Angeles CA 90024 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-08-12 | 23,358 | $3.49 | 47,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.4201 to $3.5501, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- Corrects the amount that was erroneously reported as held in the Form 4 filed on June 21, 2024 with the Securities and Exchange Commission.
Billionaire Hedge Funds
